Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,075,058
-$857,357 QoQ
Shares Held
335,343
+5.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#468
of 2,821 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vestmark Advisory Solutions, Inc. holds $211,410,302 across 13 Drug Manufacturers - General names. PFE ranks #8 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
53,968 | $64,730,841 | |
| 2 | JNJ |
Johnson & Johnson
|
138,783 | $35,246,716 | |
| 3 | ABBV |
AbbVie Inc.
|
126,735 | $31,891,592 | |
| 4 | AZN |
Astrazeneca PLC
|
85,578 | $16,227,298 | |
| 5 | MRK |
Merck & Co., Inc.
|
111,985 | $14,390,071 | |
| 6 | NVS |
Novartis AG
|
81,258 | $12,734,752 | |
| 7 | AMGN |
Amgen Inc
|
28,753 | $10,412,035 | |
| 8 | PFE |
Pfizer Inc
This page
|
335,343 | $8,075,058 |
All Filings in PFE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,075,058 | 335,343 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $8,932,415 | 318,106 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,032,354 | 41,460 | Shares | Other | 2026-02-06 | |
| 2025-09-30 | $504,503 | 19,800 | Shares | Other | 2025-11-10 | |
| 2025-03-31 | $474,466 | 18,724 | Shares | Other | 2025-05-13 | |
| 2024-09-30 | $256,929 | 8,878 | Shares | Other | 2024-11-14 | |
| 2023-09-30 | $1,236,975 | 37,292 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $7,133,709 | 194,485 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $8,040,169 | 197,063 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $9,575,166 | 186,869 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $7,891,678 | 180,340 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $8,314,506 | 158,583 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $6,539,172 | 126,312 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $7,204,572 | 122,008 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $5,182,618 | 120,498 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,304,976 | 109,933 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $4,165,689 | 114,979 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $4,232,892 | 114,993 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $4,083,751 | 111,274 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $4,136,096 | 126,486 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,543,211 | 169,829 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||